Էջ 1 սկսած 30 արդյունքներ
FIELD OF THE INVENTION
The present invention relates to novel thyroid receptor ligands and, more particularly, relates to novel cyano containing oxamic acids, and derivatives thereof, which are useful in the treatment of obesity, hyperlipidemia, thyroid disease, hypothyroidism and related disorders
FIELD OF THE INVENTION
The present invention relates to novel thyroid receptor ligands and, more particularly, relates to novel oxamic acids, and derivatives thereof, which are useful in the treatment of obesity, hyperlipidemia, glaucoma, cardiac arrhythmia, skin disorders, thyroid disease,
FIELD OF THE INVENTION
The present invention relates to novel thyroid receptor ligands and, more particularly, relates to novel oxamic acids, and derivatives thereof, which are useful in the treatment of obesity, hyperlipidemia, glaucoma, cardiac arrhythmia, skin disorders, thyroid disease,
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to novel compounds which are thyroid receptor ligands, and are preferably selective for the thyroid hormone receptor .beta., to methods of preparing such compounds and to methods for using such compounds such as in the
FIELD OF THE INVENTION
This invention relates to novel compounds which are thyroid receptor ligands, and are preferably selective for the thyroid hormone receptor .beta., and to methods of preparing such compounds and to methods for using such compounds such as in the regulation of
FIELD OF THE INVENTION
This invention relates to novel compounds which are thyroid receptor ligands, and are preferably selective for the thyroid hormone receptor .beta., and to methods of preparing such compounds and to methods for using such compounds such as in the regulation of
BACKGROUND OF THE INVENTION
Hyperlipidemia and hypercholesterolemia are conditions that have a well established correlation with increased risk of other conditions, such as heart attacks, atherosclerosis, and other deleterious ailments. There are numerous agents available for lowering cholesterol
BACKGROUND OF THE INVENTION
Hyperlipidemia and hypercholesterolemia are conditions that have a well established correlation with increased risk of other conditions, such as heart attacks, atherosclerosis, and other deleterious ailments. There are numerous agents available for lowering cholesterol
BACKGROUND OF THE INVENTION
Hyperlipidemia and hypercholesterolemia are conditions that have a well established correlation with increased risk of other conditions, such as heart attacks, atherosclerosis, and other deleterious ailments. There are numerous agents available for lowering cholesterol
BACKGROUND OF THE INVENTION
Hyperlipidemia and hypercholesterolemia are conditions that have a well established correlation with increased risk of other conditions, such as heart attacks, atherosclerosis, and other deleterious ailments. There are numerous agents available for lowering cholesterol
BACKGROUND OF THE INVENTION
The present invention relates to novel thyroid receptor ligands and, more preferably, relates to indole carboxylic acids, and derivatives thereof, which are useful in the treatment of obesity, overweight condition, hyperlipidemia, glaucoma, cardiac arrhythmias, skin
FIELD OF THE INVENTION
This invention relates to novel compounds which are thyroid receptor ligands, and are preferably selective for the thyroid hormone receptor .beta., and to methods of preparing such compounds and to methods for using such compounds such as in the regulation of
FIELD OF THE INVENTION
This invention relates to novel compounds which are thyroid receptor ligands, and are preferably selective for the thyroid hormone receptor .beta., to methods of preparing such compounds and to methods for using such compounds such as in the regulation of
FIELD OF THE INVENTION
This invention relates to novel compounds which are thyroid receptor ligands, and are preferably selective for the thyroid hormone receptor .beta., to methods of preparing such compounds and to methods for using such compounds such as in the regulation of
The invention relates to novel diphenyl derivatives, to processes for their preparation and to their use in medicaments.
EP-A-580 550 describes oxamic acid derivatives having cholesterol-lowering properties in mammals. The pharmacological property that is emphasized is the reduction of plasma